Medical Devices News and Research

RSS

Australia approves Fziomed’s new viscoelastic gel

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG).

From Medtronic 6 May 2013

STD Med receives second Certificate of Good Practices for Manufacturing of Class III Medical Devices

STD Med, Inc. is pleased to announce that it has received a second Certificate of Good Practices for Manufacturing of Class III Medical Devices from ANVISA, the Brazilian National Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria –ANVISA).

5 May 2013

Obama 'comfortable' with morning-after pill sales at 15

President Barack Obama said he is "very comfortable" with the Food and Drug Administration rule announced this week to make the so-called morning after pill available without a prescription to women and girls who are at least 15 -- younger than the current limit of 17.

4 May 2013

Hospitals warn of lost jobs, patient services after proposed payment changes

Changes in how hospitals are paid make news in Minnesota -- where the state's largest health plan will delay a new payment system -- and Maryland -- where hospitals say a cut in pay to them will mean fewer jobs and patient services.

3 May 2013

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

NeuroSigma, Inc., a California-based medical device company, today announced that it has received a Class 2 medical device license for its Monarch eTNS (external trigeminal nerve stimulation) System from Health Canada.

2 May 2013

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.

30 Apr 2013

CVRx enrolls first patient in Barostim HOPE4HF clinical trial

CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.

29 Apr 2013

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.

26 Apr 2013

Latin America facing an alarming increase in cancer rates

Latin America is facing an alarming increase in cancer rates, and unless urgent action is taken to prevent cancers, improve health-care systems and facilities, access to vital medical care, and treatment of poor people, the region threatens to be overwhelmed by the burgeoning epidemic, say the authors of a major new report on cancer control in the region, published in The Lancet Oncology, and launched at the Latin American Cooperative Oncology Group (LACOG) 2013 conference in São Paulo, Brazil.

26 Apr 2013

DJO Global reports first quarter results for 2013

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter ended March 30, 2013.

26 Apr 2013

Covidien net sales increase 5% to $3.10 billion in second quarter 2013

Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.

26 Apr 2013

Viewpoints: GOP rebranding effort spurs revolt; will health law help or hurt Democrats in next campaign?

When even a key architect of Obamacare says the law's implementation will resemble a "train wreck," it is clear that its biggest remaining supporters need to finally level with the American people about what's in store - starting with President Barack Obama.

26 Apr 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.

26 Apr 2013

Comparison of processability of medical resins reveals effect of physical properties on moldability

Both physical properties and processability play key roles when injection-molded parts are mass produced. When producing medical parts, a consistent, high degree of accuracy is also vital. It is relatively simple to adjust a process to account for differences in molecular weight once that process is optimized for a specific polymer. It is much more complex to adjust the process for changes in polymers.

25 Apr 2013

LCMD plans initial commercialization of Keyhole Cup Laparoscopic Access Device in Q3 2013

Life Care Medical Devices Ltd today announced the issuance in August 2012 of CE mark for its Keyhole Cup Laparoscopic Access Device.

25 Apr 2013

Viewpoints: Physician payment sunshine rules may not stop conflicts of interest; Support wanes for health law

The federal Center for Medicare & Medicaid Services recently announced final regulations for the Physician Payment Sunshine Act, which requires pharmaceutical and medical-device companies to disclose payments they make to doctors, hospitals and other health-care providers.

25 Apr 2013

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.

25 Apr 2013

Researchers decode toggle switch that can stimulate fat burning

For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.

24 Apr 2013

Pediatric nurse scientist awarded AACN Impact Research Grant

The American Association of Critical-Care Nurses recently awarded a $50,000 AACN Impact Research Grant to Martha A.Q. Curley, RN, PhD, FAAN, a leading clinical scientist in pediatric critical care nursing.

24 Apr 2013

AACN awards Impact Research Grant to Detroit palliative care expert

The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.

24 Apr 2013

Medical Devices News and Research

Australia approves Fziomed’s new viscoelastic gel

STD Med receives second Certificate of Good Practices for Manufacturing of Class III Medical Devices

Obama 'comfortable' with morning-after pill sales at 15

Hospitals warn of lost jobs, patient services after proposed payment changes

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

CVRx enrolls first patient in Barostim HOPE4HF clinical trial

Derma Sciences initiates patient screening in DSC127 pivotal program for treatment of diabetic foot ulcers

Latin America facing an alarming increase in cancer rates

DJO Global reports first quarter results for 2013

Covidien net sales increase 5% to $3.10 billion in second quarter 2013

Viewpoints: GOP rebranding effort spurs revolt; will health law help or hurt Democrats in next campaign?

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Comparison of processability of medical resins reveals effect of physical properties on moldability

LCMD plans initial commercialization of Keyhole Cup Laparoscopic Access Device in Q3 2013

Viewpoints: Physician payment sunshine rules may not stop conflicts of interest; Support wanes for health law

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

Researchers decode toggle switch that can stimulate fat burning

Pediatric nurse scientist awarded AACN Impact Research Grant

AACN awards Impact Research Grant to Detroit palliative care expert

Industry Focus eBook - Medical Devices (3rd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News